We are live on
!
Find out more
TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
1-Year Est. Return
58.09%
This Fund
S&P 500
This Quarter
Est. Return
-11.96%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$154M
AUM Growth
-$169M
(-52%)
Cap. Flow
-$150M
Cap. Flow
% of AUM
-97.18%
Top 10 Holdings %
Top 10 Hldgs %
83.53%
Holding
39
New
5
Increased
3
Reduced
12
Closed
18
Top Buys
| 1 |
Becton Dickinson
BDX
|
+$2.7M |
| 2 |
AngioDynamics
ANGO
|
+$83.2K |
Top Sells
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$6.5M |
| 2 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
+$6.49M |
| 3 |
Viatris
VTRS
|
+$5.99M |
| 4 |
Tenet Healthcare
THC
|
+$5.61M |
| 5 |
Abbott
ABT
|
+$4.91M |
Sector Composition
| 1 | Healthcare | 32.49% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$782B
| $64.1M | 41.52% |
150,000
-250,000
| -63% | -$111M |
|
|
2
CALL
Becton Dickinson
BDX
$44.1B
| $16.8M | 10.88% |
+65,000
| New | +$17.6M |
|
3
CALL
DexCom
DXCM
$30.1B
| $9.33M | 6.04% |
+100,000
| New | +$11.3M |
|
|
4
Viatris
VTRS
$20.2B
| $6.66M | 4.31% |
675,000
-575,000
| -46% | -$5.99M |
|
|
5
Becton Dickinson
BDX
$44.1B
| $6.46M | 4.19% |
25,000
+10,000
| +67% | +$2.7M |
|
|
6
CALL
Viatris
VTRS
$20.2B
| $5.92M | 3.83% |
+600,000
| New | +$6.25M |
|
|
MDRX
7
DELISTED
Veradigm Inc. Common Stock
MDRX
| $5.72M | 3.7% |
435,000
-495,000
| -53% | -$6.49M |
|
8
McKesson
MCK
$98.5B
| $4.78M | 3.1% |
11,000
-3,000
| -21% | -$1.26M |
|
|
STRM
9
DELISTED
Streamline Health Solutions
STRM
| $4.77M | 3.09% |
328,725
| – | – |
|
10
CALL
iShares S&P 100 ETF
OEF
$20.4B
| $4.43M | 2.87% |
+50,000
| New | +$10.4M |
|
11
Collegium Pharmaceutical
COLL
$1.18B
| $4.13M | 2.68% |
185,000
-190,000
| -51% | -$4.33M |
|
12
Phreesia
PHR
$673M
| $4.02M | 2.6% |
215,000
-75,000
| -26% | -$2.02M |
|
|
13
AngioDynamics
ANGO
$584M
| $3.47M | 2.25% |
475,000
+10,000
| +2% | +$83.2K |
|
14
Tactile Systems Technology
TCMD
$663M
| $3.36M | 2.18% |
239,222
-60,778
| -20% | -$1.19M |
|
|
MDRX
15
CALL
DELISTED
Veradigm Inc. Common Stock
MDRX
| $2.63M | 1.7% |
200,000
+100,000
| +100% | +$1.31M |
|
16
AtriCure
ATRC
$1.8B
| $1.75M | 1.13% |
40,000
-45,000
| -53% | -$2.2M |
|
17
Sanofi
SNY
$106B
| $1.61M | 1.04% |
30,000
-65,000
| -68% | -$3.47M |
|
|
18
Tenet Healthcare
THC
$17.2B
| $1.32M | 0.85% |
20,000
-75,000
| -79% | -$5.61M |
|
19
SI-BONE Inc
SIBN
$786M
| $1.06M | 0.69% |
50,000
-150,000
| -75% | -$3.47M |
|
20
Cerus
CERS
$643M
| $1.05M | 0.68% |
650,000
-1,100,000
| -63% | -$2.29M |
|
21
CALL
Teva Pharmaceuticals
TEVA
$37.5B
| $1.02M | 0.66% |
+100,000
| New | +$931K |
|
|
22
Abbott
ABT
$172B
| – | – |
-45,000
| Closed | -$4.91M |
|
23
Alkermes
ALKS
$8.66B
| – | – |
-100,000
| Closed | -$3.13M |
|
24
Bio-Rad Laboratories Class A
BIO
$8.05B
| – | – |
-2,000
| Closed | -$758K |
|
|
25
BioMarin Pharmaceuticals
BMRN
$11.6B
| – | – |
-75,000
| Closed | -$6.5M |
|
Similar funds
SCM
LBC
ICM
LCMP
GIP
STC
GC
DU